Literature DB >> 33456165

Bowel perforation from malignant atrophic papulosis treated with eculizumab.

Ajithraj Sathiyaraj1, Priyanga Jayakumar2, Matthew R McGlennon1, John F Eckford3, Sandy Itwaru Anne3,4.   

Abstract

We present the case of a 57-year-old man with known cutaneous manifestations of malignant atrophic papulosis, also known as Köhlmeier-Degos disease, who developed an almost-fatal small bowel perforation following a parathyroidectomy. He required two surgical interventions during his initial hospitalization and was started on eculizumab. Despite these therapies, the patient developed recurrent bowel perforations and ultimately died.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Bowel perforation; Degos disease; eculizumab; malignant atrophic papulosis

Year:  2020        PMID: 33456165      PMCID: PMC7785204          DOI: 10.1080/08998280.2020.1809942

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  7 in total

1.  A case of Degos disease: demonstration of C5b-9-mediated vascular injury.

Authors:  Masayu Umemura; Yusuke Miwa; Ryo Yanai; Sakiko Isojima; Takahiro Tokunaga; Hiroyuki Tsukamoto; Ryo Takahashi; Nobuyuki Yajima; Tsuyoshi Kasama; Nanako Takahashi; Hirohiko Sueki; Sayaka Yamaguchi; Katsuhito Arai; Yoshiaki Takeuchi; Nobuyuki Ohike; Tomoko Norose; Toshiko Yamochi-Onizuka; Masafumi Takimoto
Journal:  Mod Rheumatol       Date:  2014-02-07       Impact factor: 3.023

2.  Case records of the Massachusetts General Hospital. Case 18-2014. A 32-Year-old man with a rash, myalgia, and weakness.

Authors:  Susan Burgin; John H Stone; Anuradha S Shenoy-Bhangle; Declan McGuone
Journal:  N Engl J Med       Date:  2014-06-12       Impact factor: 91.245

3.  Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome.

Authors:  Cynthia M Magro; Jonathan C Poe; Connie Kim; Lee Shapiro; Gerard Nuovo; Mary K Crow; Yanick J Crow
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

4.  Inefficacy of intravenous immunoglobulins and infliximab in Degos' disease.

Authors:  S De Breucker; F Vandergheynst; G Decaux
Journal:  Acta Clin Belg       Date:  2008 Mar-Apr       Impact factor: 1.264

Review 5.  Malignant atrophic papulosis (Köhlmeier-Degos disease) - a review.

Authors:  Athanasios Theodoridis; Evgenia Makrantonaki; Christos C Zouboulis
Journal:  Orphanet J Rare Dis       Date:  2013-01-14       Impact factor: 4.123

6.  Effective treatment of malignant atrophic papulosis (Köhlmeier-Degos disease) with treprostinil--early experience.

Authors:  Lee S Shapiro; Aixa E Toledo-Garcia; Jessica F Farrell
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

7.  The effects of Eculizumab on the pathology of malignant atrophic papulosis.

Authors:  Cynthia M Magro; Xuan Wang; Francine Garrett-Bakelman; Jeffrey Laurence; Lee S Shapiro; Maria T DeSancho
Journal:  Orphanet J Rare Dis       Date:  2013-11-26       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.